A comprehensive study involving over 3,100 participants marks the first effort to examine long COVID brain symptoms across various continents.
In the United States, a staggering 86% of non-hospitalized patients reported experiencing brain fog, in stark contrast to only 15% of patients in India. This research indicates that long COVID symptoms are more closely tied to income levels than to geographical factors.
The notable variances in reported symptoms are likely influenced by cultural attitudes and access to healthcare rather than inherent differences in the virus itself.
Significant Variations in Long COVID Symptoms
Findings reveal that individuals with long COVID in the U.S. report significantly higher instances of brain fog, depression, and cognitive difficulties compared to those in countries like India and Nigeria, as revealed by a large-scale international study led by Northwestern Medicine.
Researchers emphasize that these discrepancies do not imply that Americans suffer from a more severe form of the illness. Instead, the increased symptom burden could be attributed to better access to neurological and mental health services, coupled with a reduced stigma surrounding discussions of cognitive and emotional issues.
First-Ever Cross-Continental Neurological Analysis
This study represents the inaugural comparison of long COVID's neurological effects across different continents. Researchers monitored over 3,100 adults diagnosed with long COVID at academic medical facilities located in Chicago, Medellín, Colombia, Lagos, Nigeria, and Jaipur, India.
Most participants had not been hospitalized during their initial COVID infections. Among this group, 86% of U.S. patients reported brain fog, while 63% in Nigeria, 62% in Colombia, and only 15% in India reported similar experiences.
Similar trends were observed for mental health symptoms, with nearly 75% of non-hospitalized patients in the U.S. indicating feelings of depression or anxiety. In Colombia, this number fell to around 40%, while fewer than 20% of patients in Nigeria and India reported comparable distress.
Cultural Influences on Symptom Reporting
Dr. Igor Koralnik, the study's senior author and chief of neuro-infectious disease and global neurology at Northwestern University Feinberg School of Medicine, noted, "In the U.S. and Colombia, discussing mental health and cognitive issues is culturally accepted, unlike in Nigeria and India."
He added that cultural denial surrounding mood disorder symptoms, along with stigma, misconceptions, and a lack of health literacy, may lead to biased reporting. This issue is exacerbated by a shortage of mental health professionals and perceived treatment options in those regions.
The findings were published in Frontiers in Human Neuroscience.
Common Neurological Symptoms Across Regions
Throughout all countries examined, the most frequently reported neurological symptoms included brain fog, fatigue, muscle pain, headaches, dizziness, and sensory disturbances like numbness or tingling.
Sleep-related issues also varied significantly, with nearly 60% of non-hospitalized U.S. patients reporting insomnia, compared to about one-third or fewer patients in Colombia, Nigeria, and India.
Statistical analysis of symptom patterns revealed a clear division between high- and upper-middle-income countries, such as the U.S. and Colombia, and lower-middle-income countries like Nigeria and India.
Study Methodology
This observational study enrolled adults experiencing ongoing neurological symptoms post-COVID-19 infection from 2020 to 2025. Participants were recruited from four academic medical centers, including both hospitalized and non-hospitalized patients.
Symptoms were assessed using standardized neurological, cognitive, and quality-of-life evaluations available at each site, facilitating cross-regional comparisons.
The Global Importance of Long COVID
Long COVID impacts millions globally, characterized by symptoms persisting for weeks or even years following an initial COVID infection. Estimates indicate that 10-30% of adults who contract COVID develop enduring symptoms, with cognitive and neurological challenges being particularly disruptive.
The authors emphasize that long COVID "affects young and middle-aged adults in their prime, significantly impacting workforce productivity and innovation worldwide."
In this study, U.S. patients consistently reported the highest neurological and psychological burden, which "affected their quality of life and work ability," according to Koralnik, who is also co-director of the Comprehensive COVID Center at Northwestern Medicine.
Implications of the Findings
The researchers highlight the necessity for culturally sensitive screening tools and diagnostic methods for long COVID. They also stress the importance of healthcare systems capable of providing long-term care and follow-up.
Building on these insights, Koralnik and his international team are currently testing cognitive rehabilitation treatments for long COVID brain fog in Colombia and Nigeria, utilizing treatment protocols developed at the Shirley Ryan AbilityLab in Chicago.
The study is titled "A cross-continental comparative analysis of the neurological manifestations of Long COVID."